MeridianConsensus
Operator profileIrvine, United StatesData as of May 2026

Cerenovus

Cerenovus's strongest tracked position is the Neurovascular Devices Market at an estimated 0.7% share in a market growing at 8.4% CAGR.

Meridian Consensus tracks Cerenovus in 1 market across 1 industry (Healthcare). Estimated in-market revenue is $29M, the sum of share × market size across appearances — a modeled figure, not reported company revenue.

Markets tracked
1
Industries
1
Est. in-market revenue
$29M
Top market share
0.7%

Share and revenue figures are Meridian model estimates reconciled through the publish-gate validator, not audited financials. Methodology

Market positions

MarketCAGRShare
Neurovascular Devices Market8.4%0.7%

Meridian Dossier

Need diligence-grade depth on Cerenovus?

Commission a source-cited diligence dossier on Cerenovus: identity, filed financials, IP, litigation, and government exposure. Free preview first, from $299.

Cerenovus: frequently asked

Meridian Consensus tracks Cerenovus in 1 market: Neurovascular Devices Market ($4.2B), spanning Healthcare.

Cerenovus's strongest tracked position is the Neurovascular Devices Market, a $4.2B market growing at 8.4% CAGR, where it holds an estimated 0.7% share as of May 2026.

Across Meridian-tracked markets, Cerenovus's closest peers are Stryker Corporation, Medtronic plc, MicroVention, Johnson & Johnson MedTech, Penumbra, with the largest overlap in the Neurovascular Devices Market. Peer mapping is based on co-appearance in the same tracked markets.

No. Share and revenue figures on this page are model estimates produced by Meridian's research pipeline and committee-reviewed before publication; they are not audited or exchange-filed financials. Market-level sizings are reconciled against external sources during the publish gate.

Adjacent markets in Healthcare

Tracked markets in the same industry where Cerenovus is not among the named operators. Each carries Porter Five Forces, SWOT, country analysis, and a full competitor table.

Operators that compete with Cerenovus

Meridian Consensus Digest

Free · Weekly

Not ready to commission a full report? Get our weekly briefing instead: new market sizings, thesis revisions, and reconciliation updates. Signed by the research team. No sales emails.

Subscribed by teams in Corporate Development, PE, and Management Consulting. Unsubscribe in one click.